{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:35:52Z","timestamp":1783784152311,"version":"3.55.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["27043"],"award-info":[{"award-number":["27043"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente and 5x1000 funds"],"award-info":[{"award-number":["Ricerca Corrente and 5x1000 funds"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Head and Neck Squamous Cell Carcinoma (HNSCC) are classified in two main subtypes: HPV-positive (HPV+), driven by human papillomavirus (HPV) infections, and HPV-negative (HPV-), associated with environmental risk factors. Despite molecular and clinicopathological differences, neither subtype has effective tailored therapies. Since high-risk HPV oncoproteins E6\/E7 affect several epigenetic regulators, characterizing the epigenetic landscape of HPV+\u2009and HPV- HNSCC may uncover novel subtype-specific biomarkers and therapeutic targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Histone post-translational modifications were profiled in HPV+\u2009and HPV- HNSCC tissues and cell lines using super-SILAC mass spectrometry. The same analysis was performed and combined with RNA-sequencing on E6\/E7-transduced human primary keratinocytes (HKs) to identify relevant histone modifiers affected by HPV oncoproteins. Candidate gene was validated via E6\/E7-mediated-siRNA knockdown in HPV\u2009+\u2009cell lines. Western Blot, RT-qPCR and Immunohistochemistry assessed gene expression. NSD2 expression was examined in patients\u2019 tissue samples, TCGA data and 14 HNSCC cell lines. shRNA-mediated NSD2 knockdown followed by RNA-seq, cell proliferation and migration assays evaluated its oncogenic role in HNSCC. CaCl\n                      <jats:sub>2<\/jats:sub>\n                      treatments were used to investigate NSD2\u2019s role in epithelial differentiation, while ALDH-positive cells were quantified by flow-cytometry. NSD2 overexpression was used to confirm results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>HPV+\u2009HNSCC exhibited elevated H3K36me2 levels, compared to HPV-. This alteration is driven by E6\/E7-induced NSD2 upregulation. NSD2, a histone methyltransferase specific for H3K36 di-methylation is overexpressed in HPV+\u2009relative to HPV- HNSCC and in both subtypes compared to normal tissue, suggesting crucial implications in HNSCC. Functional assays revealed that NSD2 promotes cell proliferation and migration in both the subtypes. Notably, we identified a novel role for NSD2 in inhibiting epithelial cell differentiation, particularly in HPV+\u2009HNSCC, where its upregulation mediates the E6\/E7-induced differentiation blockade.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identified a novel HPV-driven epigenetic signature in HNSCC marked by increased H3K36me2 and its writer, NSD2. Our study highlights H3K36me2 as a potential biomarker for patient stratification and positions NSD2 as a promising therapeutic target across HNSCC subtypes, modulating both common and subtype-specific oncogenic pathways. Specifically, NSD2 inhibition in HPV+\u2009tumors restores epithelial differentiation, offering a potential strategy to arrest tumor progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03631-0","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:52:58Z","timestamp":1767869578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["NSD2 upregulation is driven by high-risk HPV E6\/E7 and disrupts epithelial differentiation in HPV-associated head and neck cancer"],"prefix":"10.1186","volume":"45","author":[{"given":"Lavinia","family":"Ghiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Citro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Medda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Doni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farkhondeh","family":"Ghoryani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Noberini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavio","family":"Croci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Maffini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Miccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Monteleone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Tagliabue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"De Berardinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Campaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Bonaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohssen","family":"Ansarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Chiocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"3631_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/bs.acr.2021.05.002","volume":"152","author":"GR Bhat","year":"2021","unstructured":"Bhat GR, Hyole RG, Li J. Head and neck cancer: current challenges and future perspectives. Adv Cancer Res. 2021;152:67\u2013102.","journal-title":"Adv Cancer Res"},{"issue":"6","key":"3631_CR2","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"3631_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrc.2018.11","volume":"18","author":"CR Leemans","year":"2018","unstructured":"Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer. 2018;18(5):269\u201382.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3631_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"3631_CR5","first-page":"77","volume":"33","author":"P Boscolo-Rizzo","year":"2013","unstructured":"Boscolo-Rizzo P, Del Mistro A, Bussu F, Lupato V, Baboci L, Almadori G, et al. New insights into human papillomavirus-associated head and neck squamous cell carcinoma. Acta Otorhinolaryngol Ital. 2013;33(2):77\u201387.","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"2","key":"3631_CR6","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a Bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"3631_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41571-019-0227-z","volume":"16","author":"JD Cramer","year":"2019","unstructured":"Cramer JD, Burtness B, Le QT, Ferris RL. The changing therapeutic landscape of head and neck cancer. Nat Rev Clin Oncol. 2019;16(11):669\u201383.","journal-title":"Nat Rev Clin Oncol"},{"key":"3631_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcancer.2013.11.002","volume":"26","author":"M Tommasino","year":"2014","unstructured":"Tommasino M. The human papillomavirus family and its role in carcinogenesis. Semin Cancer Biol. 2014;26:13\u201321.","journal-title":"Semin Cancer Biol"},{"key":"3631_CR9","doi-asserted-by":"publisher","unstructured":"Scarth JA, Patterson MR, Morgan EL, Macdonald A. The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation. J Gen Virol. 2021;102(3). https:\/\/doi.org\/10.1099\/jgv.0.001540.","DOI":"10.1099\/jgv.0.001540"},{"key":"3631_CR10","doi-asserted-by":"publisher","first-page":"200297","DOI":"10.1016\/j.tvr.2024.200297","volume":"18","author":"JS Chong","year":"2024","unstructured":"Chong JS, Doorbar J. Modulation of epithelial homeostasis by HPV using Notch and Wnt. Tumour Virus Res. 2024;18:200297.","journal-title":"Tumour Virus Res"},{"key":"3631_CR11","doi-asserted-by":"publisher","unstructured":"White EA. Manipulation of epithelial differentiation by HPV oncoproteins. Viruses. 2019;11(4). https:\/\/doi.org\/10.3390\/v11040369.","DOI":"10.3390\/v11040369"},{"issue":"9","key":"3631_CR12","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41419-018-0919-9","volume":"9","author":"FO Enane","year":"2018","unstructured":"Enane FO, Saunthararajah Y, Korc M. Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells. Cell Death Dis. 2018;9(9):912.","journal-title":"Cell Death Dis"},{"issue":"2","key":"3631_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrc.2017.103","volume":"18","author":"H de The","year":"2018","unstructured":"de The H. Differentiation therapy revisited. Nat Rev Cancer. 2018;18(2):117\u201327.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"3631_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1042\/BST20253041","volume":"53","author":"DI Obanya","year":"2025","unstructured":"Obanya DI, Wootton LM, Morgan EL. Advances in Understanding the mechanisms of the human papillomavirus oncoproteins. Biochem Soc Trans. 2025;53(3):565\u201377.","journal-title":"Biochem Soc Trans"},{"key":"3631_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mrrev.2016.09.006","volume":"772","author":"J Durzynska","year":"2017","unstructured":"Durzynska J, Lesniewicz K, Poreba E. Human papillomaviruses in epigenetic regulations. Mutat Res Rev Mutat Res. 2017;772:36\u201350.","journal-title":"Mutat Res Rev Mutat Res"},{"key":"3631_CR16","doi-asserted-by":"publisher","unstructured":"Ghiani L, Chiocca S. High Risk-Human papillomavirus in HNSCC: present and future challenges for epigenetic therapies. Int J Mol Sci. 2022;23(7). https:\/\/doi.org\/10.3390\/ijms23073483.","DOI":"10.3390\/ijms23073483"},{"issue":"1","key":"3631_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","volume":"150","author":"MA Dawson","year":"2012","unstructured":"Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell. 2012;150(1):12\u201327.","journal-title":"Cell"},{"issue":"11","key":"3631_CR18","first-page":"e11725","volume":"12","author":"C Hillyar","year":"2020","unstructured":"Hillyar C, Rallis KS, Varghese J. Advances in epigenetic cancer therapeutics. Cureus. 2020;12(11):e11725.","journal-title":"Cureus"},{"key":"3631_CR19","doi-asserted-by":"publisher","unstructured":"Castilho RM, Squarize CH, Almeida LO. Epigenetic modifications and head and neck cancer: implications for tumor progression and resistance to therapy. Int J Mol Sci. 2017;18(7). https:\/\/doi.org\/10.3390\/ijms18071506.","DOI":"10.3390\/ijms18071506"},{"issue":"9","key":"3631_CR20","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1158\/1078-0432.CCR-10-1302","volume":"17","author":"HR Hudlebusch","year":"2011","unstructured":"Hudlebusch HR, Santoni-Rugiu E, Simon R, Ralfkiaer E, Rossing HH, Johansen JV, et al. The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors. Clin Cancer Res. 2011;17(9):2919\u201333.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"3631_CR21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.molcel.2011.08.042","volume":"44","author":"AJ Kuo","year":"2011","unstructured":"Kuo AJ, Cheung P, Chen K, Zee BM, Kioi M, Lauring J, et al. NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming. Mol Cell. 2011;44(4):609\u201320.","journal-title":"Mol Cell"},{"key":"3631_CR22","doi-asserted-by":"publisher","first-page":"6837","DOI":"10.2147\/OTT.S259873","volume":"13","author":"R Chen","year":"2020","unstructured":"Chen R, Chen Y, Zhao W, Fang C, Zhou W, Yang X, et al. The role of methyltransferase NSD2 as a potential oncogene in human solid tumors. Onco Targets Ther. 2020;13:6837\u201346.","journal-title":"Onco Targets Ther"},{"key":"3631_CR23","doi-asserted-by":"publisher","first-page":"105412","DOI":"10.1016\/j.archoralbio.2022.105412","volume":"138","author":"L Zhang","year":"2022","unstructured":"Zhang L, Hu G. NSD2 activates the E2F transcription factor 1\/Y-box binding protein 2 axis to promote the malignant development of oral squamous cell carcinoma. Arch Oral Biol. 2022;138:105412.","journal-title":"Arch Oral Biol"},{"issue":"2","key":"3631_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1158\/1541-7786.MCR-14-0292-T","volume":"13","author":"V Saloura","year":"2015","unstructured":"Saloura V, Cho HS, Kiyotani K, Alachkar H, Zuo Z, Nakakido M, et al. WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck. Mol Cancer Res. 2015;13(2):293\u2013304.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"3631_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13027-021-00347-6","volume":"16","author":"SF Gameiro","year":"2021","unstructured":"Gameiro SF, Ghasemi F, Zeng PYF, Mundi N, Howlett CJ, Plantinga P, et al. Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis. Infect Agent Cancer. 2021;16(1):13.","journal-title":"Infect Agent Cancer"},{"issue":"8","key":"3631_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.neo.2020.05.002","volume":"22","author":"V Saloura","year":"2020","unstructured":"Saloura V, Vougiouklakis T, Bao R, Kim S, Baek S, Zewde M, et al. WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck. Neoplasia. 2020;22(8):283\u201393.","journal-title":"Neoplasia"},{"issue":"8","key":"3631_CR27","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1158\/1541-7786.MCR-20-0092","volume":"18","author":"J Pierro","year":"2020","unstructured":"Pierro J, Saliba J, Narang S, Sethia G, Saint Fleur-Lominy S, Chowdhury A, et al. The NSD2 p.E1099K mutation is enriched at relapse and confers drug resistance in a cell Context-Dependent manner in pediatric acute lymphoblastic leukemia. Mol Cancer Res. 2020;18(8):1153\u201365.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"3631_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/leu.2013.204","volume":"28","author":"JA Oyer","year":"2014","unstructured":"Oyer JA, Huang X, Zheng Y, Shim J, Ezponda T, Carpenter Z, et al. Point mutation E1099K in MMSET\/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies. Leukemia. 2014;28(1):198\u2013201.","journal-title":"Leukemia"},{"issue":"6","key":"3631_CR29","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1158\/2159-8290.CD-19-1299","volume":"10","author":"S Yuan","year":"2020","unstructured":"Yuan S, Natesan R, Sanchez-Rivera FJ, Li J, Bhanu NV, Yamazoe T, et al. Global regulation of the histone mark H3K36me2 underlies epithelial plasticity and metastatic progression. Cancer Discov. 2020;10(6):854\u201371.","journal-title":"Cancer Discov"},{"issue":"1","key":"3631_CR30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s42003-020-01186-8","volume":"3","author":"JW Park","year":"2020","unstructured":"Park JW, Kang JY, Hahm JY, Kim HJ, Seo SB. Proteosomal degradation of NSD2 by BRCA1 promotes leukemia cell differentiation. Commun Biol. 2020;3(1):462.","journal-title":"Commun Biol"},{"issue":"8","key":"3631_CR31","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41556-023-01191-z","volume":"25","author":"MS Hoetker","year":"2023","unstructured":"Hoetker MS, Yagi M, Di Stefano B, Langerman J, Cristea S, Wong LP, et al. H3K36 methylation maintains cell identity by regulating opposing lineage programmes. Nat Cell Biol. 2023;25(8):1121\u201334.","journal-title":"Nat Cell Biol"},{"issue":"12","key":"3631_CR32","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1158\/0008-5472.CAN-10-3810","volume":"71","author":"HR Hudlebusch","year":"2011","unstructured":"Hudlebusch HR, Skotte J, Santoni-Rugiu E, Zimling ZG, Lees MJ, Simon R, et al. MMSET is highly expressed and associated with aggressiveness in neuroblastoma. Cancer Res. 2011;71(12):4226\u201335.","journal-title":"Cancer Res"},{"issue":"2","key":"3631_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.devcel.2023.12.007","volume":"59","author":"EK Ko","year":"2024","unstructured":"Ko EK, Anderson A, D\u2019Souza C, Zou J, Huang S, Cho S, et al. Disruption of H3K36 methylation provokes cellular plasticity to drive aberrant glandular formation and squamous carcinogenesis. Dev Cell. 2024;59(2):187\u201398. e7.","journal-title":"Dev Cell"},{"issue":"1","key":"3631_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.molcel.2012.10.008","volume":"49","author":"IA Asangani","year":"2013","unstructured":"Asangani IA, Ateeq B, Cao Q, Dodson L, Pandhi M, Kunju LP, et al. Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer. Mol Cell. 2013;49(1):80\u201393.","journal-title":"Mol Cell"},{"issue":"6287","key":"3631_CR35","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1126\/science.aac7272","volume":"352","author":"C Lu","year":"2016","unstructured":"Lu C, Jain SU, Hoelper D, Bechet D, Molden RC, Ran L, et al. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape. Science. 2016;352(6287):844\u20139.","journal-title":"Science"},{"issue":"6","key":"3631_CR36","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41416-019-0394-9","volume":"120","author":"S Citro","year":"2019","unstructured":"Citro S, Bellini A, Miccolo C, Ghiani L, Carey TE, Chiocca S. Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for DeltaNp63alpha. Br J Cancer. 2019;120(6):658\u201367.","journal-title":"Br J Cancer"},{"issue":"5","key":"3631_CR37","doi-asserted-by":"publisher","first-page":"E207","DOI":"10.1002\/ijc.29112","volume":"136","author":"NC Olthof","year":"2015","unstructured":"Olthof NC, Huebbers CU, Kolligs J, Henfling M, Ramaekers FC, Cornet I, et al. Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines. Int J Cancer. 2015;136(5):E207\u201318.","journal-title":"Int J Cancer"},{"issue":"21","key":"3631_CR38","first-page":"6098","volume":"49","author":"TE Carey","year":"1989","unstructured":"Carey TE, Van Dyke DL, Worsham MJ, Bradford CR, Babu VR, Schwartz DR, et al. Characterization of human laryngeal primary and metastatic squamous cell carcinoma cell lines UM-SCC-17A and UM-SCC-17B. Cancer Res. 1989;49(21):6098\u2013107.","journal-title":"Cancer Res"},{"issue":"3","key":"3631_CR39","doi-asserted-by":"publisher","first-page":"e1006262","DOI":"10.1371\/journal.ppat.1006262","volume":"13","author":"D Mattoscio","year":"2017","unstructured":"Mattoscio D, Casadio C, Miccolo C, Maffini F, Raimondi A, Tacchetti C, et al. Autophagy regulates UBC9 levels during viral-mediated tumorigenesis. PLoS Pathog. 2017;13(3):e1006262.","journal-title":"PLoS Pathog"},{"issue":"11","key":"3631_CR40","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41419-023-06248-3","volume":"14","author":"A Medda","year":"2023","unstructured":"Medda A, Compagnoni M, Spini G, Citro S, Croci O, Campaner S, et al. c-MYC-dependent transcriptional Inhibition of autophagy is implicated in cisplatin sensitivity in HPV-positive head and neck cancer. Cell Death Dis. 2023;14(11):719.","journal-title":"Cell Death Dis"},{"key":"3631_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ymeth.2019.10.001","volume":"184","author":"R Noberini","year":"2020","unstructured":"Noberini R, Restellini C, Savoia EO, Bonaldi T. Enrichment of histones from patient samples for mass spectrometry-based analysis of post-translational modifications. Methods. 2020;184:19\u201328.","journal-title":"Methods"},{"key":"3631_CR42","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/bs.mie.2016.09.036","volume":"586","author":"R Noberini","year":"2017","unstructured":"Noberini R, Bonaldi T. A Super-SILAC strategy for the accurate and multiplexed profiling of histone posttranslational modifications. Methods Enzymol. 2017;586:311\u201332.","journal-title":"Methods Enzymol"},{"key":"3631_CR43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-1-0716-2863-8_7","volume":"2603","author":"R Noberini","year":"2023","unstructured":"Noberini R, Longhi E, Bonaldi T. A Super-SILAC approach for profiling histone posttranslational modifications. Methods Mol Biol. 2023;2603:87\u2013102.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"3631_CR44","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13148-021-01120-7","volume":"13","author":"R Noberini","year":"2021","unstructured":"Noberini R, Savoia EO, Brandini S, Greco F, Marra F, Bertalot G, et al. Spatial epi-proteomics enabled by histone post-translational modification analysis from low-abundance clinical samples. Clin Epigenetics. 2021;13(1):145.","journal-title":"Clin Epigenetics"},{"issue":"7","key":"3631_CR45","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1021\/acs.jproteome.8b00133","volume":"17","author":"ZF Yuan","year":"2018","unstructured":"Yuan ZF, Sidoli S, Marchione DM, Simithy J, Janssen KA, Szurgot MR, et al. EpiProfile 2.0: A computational platform for processing Epi-Proteomics mass spectrometry data. J Proteome Res. 2018;17(7):2533\u201341.","journal-title":"J Proteome Res"},{"issue":"7","key":"3631_CR46","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"3631_CR47","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol Y, Bai J, Bandla C, Garcia-Seisdedos D, Hewapathirana S, Kamatchinathan S, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50(D1):D543\u201352.","journal-title":"Nucleic Acids Res"},{"key":"3631_CR48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fgene.2016.00075","volume":"7","author":"V Bianchi","year":"2016","unstructured":"Bianchi V, Ceol A, Ogier AG, de Pretis S, Galeota E, Kishore K, et al. Integrated systems for NGS data management and analysis: open issues and available solutions. Front Genet. 2016;7:75.","journal-title":"Front Genet"},{"issue":"4","key":"3631_CR49","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14(4):R36.","journal-title":"Genome Biol"},{"issue":"12","key":"3631_CR50","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"43","key":"3631_CR51","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3631_CR52","doi-asserted-by":"publisher","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, Mcart DG, Dunne PD et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7. https:\/\/doi.org\/10.1038\/s41598-017-17204-5.","DOI":"10.1038\/s41598-017-17204-5"},{"key":"3631_CR53","doi-asserted-by":"crossref","unstructured":"Schmidt U, Weigert M, Broaddus C, Myers G. Cell Detection with Star-Convex Polygons. Pt Ii. 2018;11071:265\u201373. Medical Image Computing and Computer Assisted Intervention - Micca. 2018.","DOI":"10.1007\/978-3-030-00934-2_30"},{"key":"3631_CR54","doi-asserted-by":"publisher","unstructured":"Weigert M, Schmidt U, Haase R, Sugawara K, Myers G. Star-convex Polyhedra for 3D Object Detection and Segmentation in Microscopy. 2020 Ieee Winter Conference on Applications of Computer Vision (Wacv). 2020:3655-62. https:\/\/doi.org\/10.1109\/WACV45572.2020.9093435.","DOI":"10.1109\/WACV45572.2020.9093435"},{"key":"3631_CR55","doi-asserted-by":"publisher","unstructured":"Weigert M, Schmidt U. Ieee Isbi. Nuclei Instance Segmentation and Classification in Histopathology Images with Stardist. 2022 Ieee International Symposium on Biomedical Imaging Challenges (2022). 2022. https:\/\/doi.org\/10.1109\/ISBIC56247.2022.9854534.","DOI":"10.1109\/ISBIC56247.2022.9854534"},{"issue":"1","key":"3631_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer C, Wang T, Michaelos M, Pachitariu M. Cellpose: a generalist algorithm for cellular segmentation. Nat Methods. 2021;18(1):100\u2013.","journal-title":"Nat Methods"},{"issue":"5","key":"3631_CR57","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"issue":"269","key":"3631_CR58","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.","journal-title":"Sci Signal"},{"issue":"1","key":"3631_CR59","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00784-023-05425-0","volume":"28","author":"TC Fonseca","year":"2023","unstructured":"Fonseca TC, Jural LA, Maranon-Vasquez GA, Magno MB, Roza A, Ferreira D, et al. Global prevalence of human papillomavirus-related oral and oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis. Clin Oral Investig. 2023;28(1):62.","journal-title":"Clin Oral Investig"},{"issue":"3","key":"3631_CR60","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1074\/mcp.M115.054510","volume":"15","author":"R Noberini","year":"2016","unstructured":"Noberini R, Uggetti A, Pruneri G, Minucci S, Bonaldi T. Pathology Tissue-quantitative mass spectrometry analysis to profile histone Post-translational modification patterns in patient samples. Mol Cell Proteom. 2016;15(3):866\u201377.","journal-title":"Mol Cell Proteom"},{"key":"3631_CR61","doi-asserted-by":"publisher","unstructured":"Noberini R, Restellini C, Savoia EO, Raimondi F, Ghiani L, Jodice MG et al. Profiling of epigenetic features in clinical samples reveals novel widespread changes in cancer. Cancers (Basel). 2019;11(5). https:\/\/doi.org\/10.3390\/cancers11050723.","DOI":"10.3390\/cancers11050723"},{"issue":"1","key":"3631_CR62","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/rmv.1822","volume":"25","author":"J Doorbar","year":"2015","unstructured":"Doorbar J, Egawa N, Griffin H, Kranjec C, Murakami I. Human papillomavirus molecular biology and disease association. Rev Med Virol. 2015;25(1):2\u201323.","journal-title":"Rev Med Virol"},{"issue":"1","key":"3631_CR63","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1182\/blood-2010-07-298349","volume":"117","author":"E Martinez-Garcia","year":"2011","unstructured":"Martinez-Garcia E, Popovic R, Min DJ, Sweet SM, Thomas PM, Zamdborg L, et al. The MMSET histone Methyl transferase switches global histone Methylation and alters gene expression in t(4;14) multiple myeloma cells. Blood. 2011;117(1):211\u201320.","journal-title":"Blood"},{"key":"3631_CR64","doi-asserted-by":"publisher","first-page":"111294","DOI":"10.1016\/j.cellsig.2024.111294","volume":"121","author":"G He","year":"2024","unstructured":"He G, Ke Y, Yuan J, Zhang B, Dai L, Liu J, et al. NSD2-mediated H3K36me2 exacerbates osteoporosis via activation of hoxa2 in bone marrow mesenchymal stem cells. Cell Signal. 2024;121:111294.","journal-title":"Cell Signal"},{"issue":"2","key":"3631_CR65","doi-asserted-by":"publisher","first-page":"100151","DOI":"10.1016\/j.cellin.2024.100151","volume":"3","author":"L He","year":"2024","unstructured":"He L, Cao Y, Sun L. NSD family proteins: rising stars as therapeutic targets. Cell Insight. 2024;3(2):100151.","journal-title":"Cell Insight"},{"issue":"7","key":"3631_CR66","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00018-017-2701-z","volume":"75","author":"E Soares","year":"2018","unstructured":"Soares E, Zhou H. Master regulatory role of p63 in epidermal development and disease. Cell Mol Life Sci. 2018;75(7):1179\u201390.","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"3631_CR67","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1097\/01.mlg.0000149437.35855.4b","volume":"114","author":"JC Sniezek","year":"2004","unstructured":"Sniezek JC, Matheny KE, Westfall MD, Pietenpol JA. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma. Laryngoscope. 2004;114(12):2063\u201372.","journal-title":"Laryngoscope"},{"key":"3631_CR68","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fcimb.2020.00143","volume":"10","author":"S Citro","year":"2020","unstructured":"Citro S, Bellini A, Medda A, Sabatini ME, Tagliabue M, Chu F, et al. Human papilloma virus increases DeltaNp63alpha expression in head and neck squamous cell carcinoma. Front Cell Infect Microbiol. 2020;10:143.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"3631_CR69","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.tcb.2022.08.003","volume":"33","author":"ML Fisher","year":"2023","unstructured":"Fisher ML, Balinth S, Mills AA. DeltaNp63alpha in cancer: importance and therapeutic opportunities. Trends Cell Biol. 2023;33(4):280\u201392.","journal-title":"Trends Cell Biol"},{"issue":"12","key":"3631_CR70","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.oraloncology.2014.08.018","volume":"50","author":"C Zhou","year":"2014","unstructured":"Zhou C, Sun B. The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis. Oral Oncol. 2014;50(12):1144\u20138.","journal-title":"Oral Oncol"},{"issue":"4","key":"3631_CR71","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41419-019-1478-4","volume":"10","author":"S Mahanty","year":"2019","unstructured":"Mahanty S, Dakappa SS, Shariff R, Patel S, Swamy MM, Majumdar A, et al. Keratinocyte differentiation promotes ER stress-dependent lysosome biogenesis. Cell Death Dis. 2019;10(4):269.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3631_CR72","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0014-4827(83)90115-5","volume":"143","author":"H Hennings","year":"1983","unstructured":"Hennings H, Holbrook KA. Calcium regulation of cell-cell contact and differentiation of epidermal cells in culture. An ultrastructural study. Exp Cell Res. 1983;143(1):127\u201342.","journal-title":"Exp Cell Res"},{"issue":"5","key":"3631_CR73","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.celrep.2018.10.007","volume":"25","author":"H Cheng","year":"2018","unstructured":"Cheng H, Yang X, Si H, Saleh AD, Xiao W, Coupar J, et al. Genomic and transcriptomic characterization links cell lines with aggressive head and neck cancers. Cell Rep. 2018;25(5):1332\u2013e455.","journal-title":"Cell Rep"},{"issue":"1","key":"3631_CR74","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13073-017-0419-z","volume":"9","author":"D Degli Esposti","year":"2017","unstructured":"Degli Esposti D, Sklias A, Lima SC, Beghelli-de la Forest Divonne S, Cahais V, Fernandez-Jimenez N, et al. Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas. Genome Med. 2017;9(1):33.","journal-title":"Genome Med"},{"issue":"2","key":"3631_CR75","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng.3757","volume":"49","author":"S Papillon-Cavanagh","year":"2017","unstructured":"Papillon-Cavanagh S, Lu C, Gayden T, Mikael LG, Bechet D, Karamboulas C, et al. Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas. Nat Genet. 2017;49(2):180\u20135.","journal-title":"Nat Genet"},{"issue":"2","key":"3631_CR76","doi-asserted-by":"publisher","first-page":"e56823","DOI":"10.1371\/journal.pone.0056823","volume":"8","author":"V Walter","year":"2013","unstructured":"Walter V, Yin X, Wilkerson MD, Cabanski CR, Zhao N, Du Y, et al. Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes. PLoS ONE. 2013;8(2):e56823.","journal-title":"PLoS ONE"},{"issue":"18","key":"3631_CR77","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1158\/0008-5472.CAN-23-3594","volume":"84","author":"P Diao","year":"2024","unstructured":"Diao P, Dai Y, Wang A, Bu X, Wang Z, Li J, et al. Integrative multiomics analyses identify molecular subtypes of head and neck squamous cell carcinoma with distinct therapeutic vulnerabilities. Cancer Res. 2024;84(18):3101\u201317.","journal-title":"Cancer Res"},{"issue":"18","key":"3631_CR78","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.1158\/1078-0432.CCR-16-0323","volume":"22","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Koneva LA, Virani S, Arthur AE, Virani A, Hall PB, et al. Subtypes of HPV-Positive head and neck cancers are associated with HPV Characteristics, copy number Alterations, PIK3CA Mutation, and pathway signatures. Clin Cancer Res. 2016;22(18):4735\u201345.","journal-title":"Clin Cancer Res"},{"key":"3631_CR79","doi-asserted-by":"publisher","unstructured":"Qin T, Li S, Henry LE, Liu S, Sartor MA. Molecular tumor subtypes of HPV-Positive head and neck cancers: biological characteristics and implications for clinical outcomes. Cancers (Basel). 2021;13(11). https:\/\/doi.org\/10.3390\/cancers13112721.","DOI":"10.3390\/cancers13112721"},{"issue":"19","key":"3631_CR80","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1038\/s41388-018-0659-4","volume":"38","author":"I Carrero","year":"2019","unstructured":"Carrero I, Liu HC, Sikora AG, Milosavljevic A. Histoepigenetic analysis of HPV- and tobacco-associated head and neck cancer identifies both subtype-specific and common therapeutic targets despite divergent microenvironments. Oncogene. 2019;38(19):3551\u201368.","journal-title":"Oncogene"},{"issue":"4","key":"3631_CR81","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.3892\/or.2017.5463","volume":"37","author":"Z Yin","year":"2017","unstructured":"Yin Z, Sun Y, Ge S, Sun J. Epigenetic activation of WHSC1 functions as an oncogene and is associated with poor prognosis in cervical cancer. Oncol Rep. 2017;37(4):2286\u201394.","journal-title":"Oncol Rep"},{"issue":"21","key":"3631_CR82","doi-asserted-by":"publisher","first-page":"10999","DOI":"10.1128\/JVI.00160-11","volume":"85","author":"PL Hyland","year":"2011","unstructured":"Hyland PL, McDade SS, McCloskey R, Dickson GJ, Arthur K, McCance DJ, et al. Evidence for alteration of EZH2, BMI1, and KDM6A and epigenetic reprogramming in human papillomavirus type 16 E6\/E7-expressing keratinocytes. J Virol. 2011;85(21):10999\u20131006.","journal-title":"J Virol"},{"issue":"3","key":"3631_CR83","doi-asserted-by":"publisher","first-page":"e70278","DOI":"10.1002\/jmv.70278","volume":"97","author":"L Galati","year":"2025","unstructured":"Galati L, Tagliabue M, Gheit T, De Berardinis R, Maffini F, McKay-Chopin S, et al. HPV biomarkers in oral and Blood-Derived body fluids in head and neck cancer patients. J Med Virol. 2025;97(3):e70278.","journal-title":"J Med Virol"},{"key":"3631_CR84","doi-asserted-by":"publisher","unstructured":"Meng R, Gao Y, Peng Z, Chen H, Li Y, Liu Y et al. Development and validation of a small extracellular vesicle-derived RNA signature for early diagnosis of lung adenocarcinoma and prognosis in advanced stages. Mol Cancer. 2025. https:\/\/doi.org\/10.1186\/s12943-025-02524-2.","DOI":"10.1186\/s12943-025-02524-2"},{"issue":"1","key":"3631_CR85","doi-asserted-by":"publisher","first-page":"16335","DOI":"10.1038\/s41598-023-43520-0","volume":"13","author":"P Van den Ackerveken","year":"2023","unstructured":"Van den Ackerveken P, Lobbens A, Pamart D, Kotronoulas A, Rommelaere G, Eccleston M, et al. Epigenetic profiles of elevated cell free Circulating H3.1 nucleosomes as potential biomarkers for non-Hodgkin lymphoma. Sci Rep. 2023;13(1):16335.","journal-title":"Sci Rep"},{"key":"3631_CR86","doi-asserted-by":"publisher","first-page":"109344","DOI":"10.1016\/j.bioorg.2025.109344","volume":"168","author":"Z Zuo","year":"2025","unstructured":"Zuo Z, Ran J, Zhou Y, Chen M. Targeting nuclear receptor-binding SET domain protein 2 (NSD2) for cancer therapy: challenges and emerging strategies. Bioorg Chem. 2025;168:109344.","journal-title":"Bioorg Chem"},{"issue":"1","key":"3631_CR87","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/jop.12074","volume":"43","author":"L Loljung","year":"2014","unstructured":"Loljung L, Coates PJ, Nekulova M, Laurell G, Wahlgren M, Wilms T, et al. High expression of p63 is correlated to poor prognosis in squamous cell carcinoma of the tongue. J Oral Pathol Med. 2014;43(1):14\u20139.","journal-title":"J Oral Pathol Med"},{"issue":"21","key":"3631_CR88","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1007\/s00018-020-03539-2","volume":"77","author":"M Yi","year":"2020","unstructured":"Yi M, Tan Y, Wang L, Cai J, Li X, Zeng Z, et al. TP63 links chromatin remodeling and enhancer reprogramming to epidermal differentiation and squamous cell carcinoma development. Cell Mol Life Sci. 2020;77(21):4325\u201346.","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"3631_CR89","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1158\/2159-8290.CD-18-0083","volume":"9","author":"J Zhang","year":"2019","unstructured":"Zhang J, Lee YR, Dang F, Gan W, Menon AV, Katon JM, et al. PTEN methylation by NSD2 controls cellular sensitivity to DNA damage. Cancer Discov. 2019;9(9):1306\u201323.","journal-title":"Cancer Discov"},{"issue":"1","key":"3631_CR90","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s42003-024-06395-z","volume":"7","author":"S Weirich","year":"2024","unstructured":"Weirich S, Kusevic D, Schnee P, Reiter J, Pleiss J, Jeltsch A. Discovery of NSD2 non-histone substrates and design of a super-substrate. Commun Biol. 2024;7(1):707.","journal-title":"Commun Biol"},{"issue":"1","key":"3631_CR91","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1038\/s41467-019-12811-4","volume":"10","author":"P Lhoumaud","year":"2019","unstructured":"Lhoumaud P, Badri S, Rodriguez-Hernaez J, Sakellaropoulos T, Sethia G, Kloetgen A, et al. NSD2 overexpression drives clustered chromatin and transcriptional changes in a subset of insulated domains. Nat Commun. 2019;10(1):4843.","journal-title":"Nat Commun"},{"issue":"9","key":"3631_CR92","doi-asserted-by":"publisher","first-page":"e1004566","DOI":"10.1371\/journal.pgen.1004566","volume":"10","author":"R Popovic","year":"2014","unstructured":"Popovic R, Martinez-Garcia E, Giannopoulou EG, Zhang Q, Zhang Q, Ezponda T, et al. Histone methyltransferase MMSET\/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation. PLoS Genet. 2014;10(9):e1004566.","journal-title":"PLoS Genet"},{"issue":"1","key":"3631_CR93","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13059-025-03483-z","volume":"26","author":"RT Wagner","year":"2025","unstructured":"Wagner RT, Hlady RA, Pan X, Wang L, Kim S, Zhao X, et al. SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylation. Genome Biol. 2025;26(1):22.","journal-title":"Genome Biol"},{"issue":"45","key":"3631_CR94","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.1038\/onc.2016.116","volume":"35","author":"MY Shah","year":"2016","unstructured":"Shah MY, Martinez-Garcia E, Phillip JM, Chambliss AB, Popovic R, Ezponda T, et al. MMSET\/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents. Oncogene. 2016;35(45):5905\u201315.","journal-title":"Oncogene"},{"issue":"33","key":"3631_CR95","doi-asserted-by":"publisher","first-page":"34494","DOI":"10.18632\/oncotarget.5417","volume":"6","author":"I Kurth","year":"2015","unstructured":"Kurth I, Hein L, Mabert K, Peitzsch C, Koi L, Cojoc M, et al. Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma. Oncotarget. 2015;6(33):34494\u2013509.","journal-title":"Oncotarget"},{"issue":"12","key":"3631_CR96","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.4161\/cbt.10.12.13432","volume":"10","author":"F Jerhammar","year":"2010","unstructured":"Jerhammar F, Ceder R, Garvin S, Grenman R, Grafstrom RC, Roberg K. Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma. Cancer Biol Ther. 2010;10(12):1244\u201351.","journal-title":"Cancer Biol Ther"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03631-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03631-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03631-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:18:35Z","timestamp":1781626715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-025-03631-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3631"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03631-0","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HKs were isolated from skin biopsies collected via standardized operative procedures approved by European Institute of Oncology Ethical Board. HNSCC patients\u2019 tissue samples were collected by the Division of Otolaryngology and Head and Neck Surgery division at the IEO Institute through IEO Biobank. Ethical approval was obtained from IEO Ethical Committee (code CE n. R1841\/23- IEO 1972), Milan, Italy. All the enrolled patients signed the informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not-Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}